Platelet counts in HFE p.C282Y/p.C282Y and wt/wt post-screening clinical evaluation participants.
Sign Up to like & getrecommendations! Published in 2023 at "Platelets"
DOI: 10.1080/09537104.2023.2217933
Abstract: Our aim was to document the effects of genotype HFE p.C282Y/p.C282Y and hemochromatosis-associated laboratory and clinical manifestations on platelet counts (PC). We compiled genotype (p.C282Y/p.C282Y or HFE wt/wt (absence of p.C282Y and p.H63D (rs1799945)), age,… read more here.
Keywords: post screening; screening clinical; c282y; hfe c282y ... See more keywords
Clinical characteristics of HFE C282Y/H63D compound heterozygotes identified in a specialty practice: key differences from HFE C282Y homozygotes
Sign Up to like & getrecommendations! Published in 2024 at "Expert Review of Hematology"
DOI: 10.1080/17474086.2024.2337950
Abstract: ABSTRACT Background Patients with p.C282Y homozygous (p.C282Y) HFE mutations are more likely to develop hemochromatosis (HC) than p.C282Y/p.H63D compound heterozygotes (p.C282Y/H63D). Research design and methods We conducted a retrospective chart review of 90 p.C282Y and… read more here.
Keywords: c282y; compound heterozygotes; c282y h63d; hfe c282y ... See more keywords